Beijing Center for Disease Prevention and Control, Beijing, China.
Beijing Research Center for Respiratory Infectious Diseases, Beijing, China.
Infect Dis Poverty. 2024 Jan 19;13(1):7. doi: 10.1186/s40249-024-01175-7.
The thirteen-valent pneumococcal conjugate vaccine (PCV13) is not included in the national immunization program and is administered voluntarily with informed consent in China. In preparation for assessing the impact of pilot introduction in Hainan Province, we conducted a carriage study among children under 5 years of age from four locations in Hainan Province, China.
From March to June 2022, nasopharyngeal (NP) swabs, collected from healthy children aged younger than 59 months who lived in the 4 different locations (Haikou, Wanning, Baisha and Qiongzhong) in Hainan Province, were tested for pneumococcus using conventional culture. Pneumococcal isolates were serotyped using the Quellung reaction. Risk factors associated with pneumococcal colonization were assessed using univariate analysis and multivariable logistic regression adjusting for age, daycare attendance and other factors.
Pneumococcus was isolated in 710 (30.4%) of the 2333 children enrolled. Of 737 pneumococci, 29 serotypes were identified; 60.9% were PCV13 serotypes; the most common vaccine serotypes were 6B (20.4%), 19F (13.0%), 6A (11.9%) and 23F (6.1%); and the most common nonvaccine serotypes were 23A (12.9%), 34 (6.1%) and nontypeable (NT) pneumococci (5.6%). Children vaccinated with PCV13 had lower carriage (17.7% vs 32.5%; P = 0.0001) and fewer PCV13 serotypes (41.9% vs 62.7%; P = 0.0017) compared to unimmunized children. After adjustment, NP carriage was higher among children attending daycare (aOR = 2.3, 95% CI: 1.7-3.2), living in rural areas (aOR = 1.4, 95% CI: 1.1-1.8), living with siblings (aOR = 1.3, 95% CI: 1.0-1.6) and whose mothers had completed senior high/technical secondary school (aOR = 1.5, 95% CI: 1.1-2.0). In contrast, completion of 3-4 doses of PCV13 were associated with a lower carriage rate (aOR = 0.6, 95% CI: 0.4-0.9).
We established the baseline of pneumococcal carriage, serotype distribution and PCV13 immunization rates among healthy children under 5 years of age in Hainan Province, prior to the introduction of PCV13 into the national immunization program. The high proportion of PCV13 serotypes suggests that PCV13 introduction will likely have a substantial impact on pneumococcal carriage in Hainan Province.
13 价肺炎球菌结合疫苗(PCV13)未被纳入国家免疫规划,在中国以知情同意的方式自愿接种。为了为在海南省进行试点引入做准备,我们在海南省的四个地点(海口、万宁、白沙和琼中)的 59 个月以下的健康儿童中进行了一项携带研究。
2022 年 3 月至 6 月,从海南省四个不同地点(海口、万宁、白沙和琼中)居住的 59 个月以下的健康儿童中采集鼻咽(NP)拭子,使用常规培养方法检测肺炎球菌。使用 Quellung 反应对肺炎球菌分离株进行血清型分型。使用单因素分析和多变量逻辑回归调整年龄、日托和其他因素,评估与肺炎球菌定植相关的危险因素。
在纳入的 2333 名儿童中,710 名(30.4%)分离出肺炎球菌。在 737 株肺炎球菌中,鉴定出 29 种血清型;60.9%为 PCV13 血清型;最常见的疫苗血清型为 6B(20.4%)、19F(13.0%)、6A(11.9%)和 23F(6.1%);最常见的非疫苗血清型为 23A(12.9%)、34(6.1%)和非分型肺炎球菌(5.6%)。接种 PCV13 的儿童携带率较低(17.7%比 32.5%;P=0.0001),携带的 PCV13 血清型较少(41.9%比 62.7%;P=0.0017)。调整后,日托儿童(aOR=2.3,95%CI:1.7-3.2)、农村地区儿童(aOR=1.4,95%CI:1.1-1.8)、有兄弟姐妹的儿童(aOR=1.3,95%CI:1.0-1.6)和母亲完成高中/中专教育的儿童(aOR=1.5,95%CI:1.1-2.0)携带 NP 的比例更高。相比之下,完成 3-4 剂 PCV13 接种与较低的携带率相关(aOR=0.6,95%CI:0.4-0.9)。
我们在海南省的 5 岁以下健康儿童中建立了肺炎球菌携带、血清型分布和 PCV13 免疫接种率的基线,为 PCV13 纳入国家免疫规划做准备。PCV13 血清型的高比例表明,PCV13 的引入可能会对海南省的肺炎球菌携带产生重大影响。